Recombinant BCL2L1 anticorps

N° du produit ABIN7127365

Cet anticorps anti-BCL2L1 est un anticorps Lapin Monoclonal détectant BCL2L1 dans WB, IHC et ELISA. Adapté pour Humain.

Aperçu rapide pour Recombinant BCL2L1 anticorps (ABIN7127365)

Antigène: BCL2L1 (BCL2-Like 1 (BCL2L1))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp BCL2L1 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Clone: 5E9

Détail du produit anti-BCL2L1 anticorps

Réactivité croisée: Humain, Souris, Rat

Purification: Affinity-chromatography

Immunogène: A synthesized peptide derived from human Bcl-XL

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: WB:1:500-1:5000, IHC:1:50-1:200,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur BCL2L1

Antigène: BCL2L1 (BCL2-Like 1 (BCL2L1))

Autre désignation: BCL2L1

Sujet:

Background: Potent inhibitor of cell death. Inhibits activation of caspases. Appears to regulate cell death by blocking the voltage-dependent anion channel (VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. Also acts as a regulator of G2 checkpoint and progression to cytokinesis during mitosis.

Aliases: Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X), BCL2L1, BCL2L BCLX

UniProt: Q07817

Pathways: Apoptose, Negative Regulation of intrinsic apoptotic Signaling